VIA
VERA icon

Virtus Investment Advisers’s Vera Therapeutics VERA Stock Holding History

Virtus Investment Advisers’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Buy
9,550
+4,076
+74% +$152K 0.1% 260
2026
Q1 		$220K Buy
5,474
+132
+2% +$5.69K 0.06% 331
2025
Q4 		$271K Buy
5,342
+290
+6% +$10.3K 0.07% 288
2025
Q3 		$147K Buy
5,052
+876
+21% +$20.3K 0.04% 379
2025
Q2 		$98.4K Buy
4,176
+539
+15% +$12.1K 0.03% 340
2025
Q1 		$87.4K Buy
+3,637
New +$117K 0.02% 439

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Virtus Investment Advisers's VERA Position: Q2 2026 in Review

Virtus Investment Advisers increased its Vera Therapeutics (VERA) stake by 74% in Q2 2026, buying an estimated $152K and bringing the position to 9,550 shares worth $410K. The position accounts for 0.1% of the portfolio, ranked #260.

Virtus Investment Advisers first reported a position in VERA in Q1 2025 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Virtus Investment Advisers held 9,550 shares of Vera Therapeutics worth $410K as of Q2 2026.
  • Virtus Investment Advisers bought 4,076 Vera Therapeutics shares in Q2 2026, an estimated $152K.
  • Vera Therapeutics made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #260 holding.
  • Virtus Investment Advisers first reported a position in Vera Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.